Founded in 1995, MédiS has obtained the operating license in June 1999. The first Market Authorization dates back to the month of February 2000. Currently, Médis has a large portfolio of proven products as well as a wide sales network.
Our range of generic drugs currently includes 60 products with 200 different presentations and 17 key therapeutic areas ... Read more
MediS is certified:
MediS currently has 600 employees’ meadows with a framing rate reaching 50%.... Read more
02.03.2015
Enhanced by the great and positive experience in the field of anesthesiology and medical reanimation, MédiS proves once again that it is the main actor in this area by launching his CISATREX® 10mg / 5ml,...
02.03.2015
MédiS philosophy, which becomes a reality, is to by provide patients high quality medicines while ensuring the economy in the management of their disease such as pain. Indeed, MédiS invests again in the management of pain by...
02.03.2015
After granting the Marketing Authorization of THE FIRST Human Recombinant alpha Erythropoietin (EPO), MédiS becomes the FIRST Tunisian pharmaceutical company to produce and market its biosimilar EPO commercially appointed as...
Copyright © 2014 MEDIS | Powered by Web Design